More on ALNY
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $229.30 |
|
|||
| Open | $229.30 | ||||
| 52 Wk High | $109.10 | ||||
| 52 Wk Low | $31.38 | ||||
| Day High | $229.30 | ||||
| Day Low | $229.30 | ||||
| P/E | N/A | ||||
| EPS | $-1.45 | ||||
| Volume | 573 | ||||
- BMO Capital Starts Alnylam Pharmaceuticals (ALNY) at Outperform
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $256 at Wells Fargo
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $455 at H.C. Wainwright
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $315 at Truist Securities
- Raymond James Upgrades Alnylam Pharmaceuticals (ALNY) to Strong Buy
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $450 at Barclays
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $375 at JPMorgan
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $316 at Wells Fargo
- Alnylam Pharmaceuticals (ALNY) PT Lowered to $350 at Oppenheimer
- Alnylam Pharma. (ALNY) PT Lowered; RBC Capital: 'Tough Update But Stock Reaction Looks Overdone'
Entities mentioned with ALNY
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Genzyme/Sanofi-Aventis | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
